BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1338695 OC(=O)[C@@H]1CCCCN1Cc1ccc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(c1)C(F)(F)F InChI=1S/C29H25F3N2O2/c30-29(31,32)26-17-20(19-34-16-5-4-11-27(34)28(35)36)12-13-23(26)15-14-22-9-6-10-24(25(22)18-33)21-7-2-1-3-8-21/h1-3,6-10,12-15,17,27H,4-5,11,16,19H2,(H,35,36) PAAUGUKJKPMTRF-UHFFFAOYSA-N 627345 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-3-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 1 Programmed cell death 1 ligand/protein 1 Homo sapiens 10.2 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627345&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005557 485655740 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338696 OC(=O)[C@@H]1CCCCN1Cc1ccc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(Cl)c1 InChI=1S/C28H25ClN2O2/c29-26-17-20(19-31-16-5-4-11-27(31)28(32)33)12-13-23(26)15-14-22-9-6-10-24(25(22)18-30)21-7-2-1-3-8-21/h1-3,6-10,12-15,17,27H,4-5,11,16,19H2,(H,32,33) JEBGPFJJIHIDOB-UHFFFAOYSA-N 627346 (S,E)-1-(3-Chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 2 Programmed cell death 1 ligand/protein 1 Homo sapiens 26.3 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627346&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005374 485655741 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338697 Cc1c(\C=C\c2ccc(CN3CCCC[C@H]3C(O)=O)cc2Cl)cccc1-c1ccccc1 InChI=1S/C28H28ClNO2/c1-20-22(10-7-11-25(20)23-8-3-2-4-9-23)15-16-24-14-13-21(18-26(24)29)19-30-17-6-5-12-27(30)28(31)32/h2-4,7-11,13-16,18,27H,5-6,12,17,19H2,1H3,(H,31,32) YNFRJQHQXXLNET-UHFFFAOYSA-N 627347 (S,E)-1-(3-Chloro-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 3 Programmed cell death 1 ligand/protein 1 Homo sapiens 87.1 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627347&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 141765561 485655742 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338698 Cc1c(\C=C\c2ccc(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C29H28F3NO2/c1-20-22(10-7-11-25(20)23-8-3-2-4-9-23)15-16-24-14-13-21(18-26(24)29(30,31)32)19-33-17-6-5-12-27(33)28(34)35/h2-4,7-11,13-16,18,27H,5-6,12,17,19H2,1H3,(H,34,35) PWHAHWLTTQKOGB-UHFFFAOYSA-N 627348 (S,E)-1-(4-(2-(2-Methyl-[1,1'-biphenyl]-3-yl)vinyl)-3-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 4 Programmed cell death 1 ligand/protein 1 Homo sapiens 10.7 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627348&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163884620 485655743 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338699 Cc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(Cl)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C29H30ClNO2/c1-20-17-24(27(30)18-25(20)19-31-16-7-6-13-28(31)29(32)33)15-14-22-11-8-12-26(21(22)2)23-9-4-3-5-10-23/h3-5,8-12,14-15,17-18,28H,6-7,13,16,19H2,1-2H3,(H,32,33) OSPXDBIJYIMOHV-UHFFFAOYSA-N 627349 (S,E)-1-(5-Chloro-2-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 5 Programmed cell death 1 ligand/protein 1 Homo sapiens 6.50 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627349&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005556 485655744 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338700 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H30F3NO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(37-2)24(17-26(23)30(31,32)33)19-34-16-7-6-13-27(34)29(35)36/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,35,36) OMRMLTBTDTUNFN-UHFFFAOYSA-N 627350 US20230331675, Compound 6::(S,E)-1-(2-Methoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 61::US20230331675, Compound 72::US20230331675, Compound 60 Programmed cell death 1 ligand/protein 1 Homo sapiens 1.60 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627350&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005277 485655745 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338701 COc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H27F3N2O3/c1-38-28-17-22(14-13-21-10-7-11-24(25(21)18-34)20-8-3-2-4-9-20)26(30(31,32)33)16-23(28)19-35-15-6-5-12-27(35)29(36)37/h2-4,7-11,13-14,16-17,27H,5-6,12,15,19H2,1H3,(H,36,37) IPRRBVIMYSUIMH-UHFFFAOYSA-N 627351 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 7 Programmed cell death 1 ligand/protein 1 Homo sapiens 1.90 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627351&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005651 485655746 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338702 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(Cl)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C29H27ClN2O2/c1-20-16-23(27(30)17-24(20)19-32-15-6-5-12-28(32)29(33)34)14-13-22-10-7-11-25(26(22)18-31)21-8-3-2-4-9-21/h2-4,7-11,13-14,16-17,28H,5-6,12,15,19H2,1H3,(H,33,34) BSMBGWKGXJRWON-UHFFFAOYSA-N 627352 (S,E)-1-(5-Chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 8 Programmed cell death 1 ligand/protein 1 Homo sapiens 1.60 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627352&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005278 485655747 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338703 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(Cl)cc1CN1CCOC[C@H]1C(O)=O InChI=1S/C28H25ClN2O3/c1-19-14-22(26(29)15-23(19)17-31-12-13-34-18-27(31)28(32)33)11-10-21-8-5-9-24(25(21)16-30)20-6-3-2-4-7-20/h2-11,14-15,27H,12-13,17-18H2,1H3,(H,32,33) KPFMRDSJYTZSSV-UHFFFAOYSA-N 627353 (S,E)-4-(5-Chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 9 Programmed cell death 1 ligand/protein 1 Homo sapiens 25.8 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627353&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163718230 485655748 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338704 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(C)cc1CN1CC=CC(=C1)C(O)=O |c:30,32| InChI=1S/C30H26N2O2/c1-21-17-27(20-32-15-7-11-26(19-32)30(33)34)22(2)16-25(21)14-13-24-10-6-12-28(29(24)18-31)23-8-4-3-5-9-23/h3-14,16-17,19H,15,20H2,1-2H3,(H,33,34) NYMUWWMIVZPAQE-UHFFFAOYSA-N 627354 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2,5-dimethylbenzyl)pyridine-3-carboxylic acid::US20230331675, Compound 10 Programmed cell death 1 ligand/protein 1 Homo sapiens 4.20 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627354&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 169489761 485655749 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338705 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(C)cc1CN1CCOC[C@H]1C(O)=O InChI=1S/C29H28N2O3/c1-20-16-25(18-31-13-14-34-19-28(31)29(32)33)21(2)15-24(20)12-11-23-9-6-10-26(27(23)17-30)22-7-4-3-5-8-22/h3-12,15-16,28H,13-14,18-19H2,1-2H3,(H,32,33) NPXCQIPIFSRQKL-UHFFFAOYSA-N 627355 (S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2,5-dimethylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 11 Programmed cell death 1 ligand/protein 1 Homo sapiens 10.1 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627355&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 168859743 485655750 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338706 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(C)cc1CN[C@@](C)(CO)C(O)=O InChI=1S/C28H28N2O3/c1-19-15-24(17-30-28(3,18-31)27(32)33)20(2)14-23(19)13-12-22-10-7-11-25(26(22)16-29)21-8-5-4-6-9-21/h4-15,30-31H,17-18H2,1-3H3,(H,32,33) QOEJZVHKOBEVTB-UHFFFAOYSA-N 627356 (S,E)-2-((4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2,5-dimethylbenzyl)amino)-3-hydroxy-2-methylpropionic acid::US20230331675, Compound 12 Programmed cell death 1 ligand/protein 1 Homo sapiens 3.40 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627356&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005649 485655751 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338707 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(Cl)cc1CN1CCNC[C@H]1C(O)=O InChI=1S/C28H26ClN3O2/c1-19-14-22(26(29)15-23(19)18-32-13-12-31-17-27(32)28(33)34)11-10-21-8-5-9-24(25(21)16-30)20-6-3-2-4-7-20/h2-11,14-15,27,31H,12-13,17-18H2,1H3,(H,33,34) BDIWSNFCBUITAA-UHFFFAOYSA-N 627357 (S,E)-1-(5-Chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methylbenzyl)piperazine-2-carboxylic acid::US20230331675, Compound 13 Programmed cell death 1 ligand/protein 1 Homo sapiens 46.0 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627357&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005248 485655752 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338708 CN1CCN(Cc2cc(Cl)c(\C=C\c3cccc(-c4ccccc4)c3C#N)cc2C)[C@@H](C1)C(O)=O InChI=1S/C29H28ClN3O2/c1-20-15-23(27(30)16-24(20)18-33-14-13-32(2)19-28(33)29(34)35)12-11-22-9-6-10-25(26(22)17-31)21-7-4-3-5-8-21/h3-12,15-16,28H,13-14,18-19H2,1-2H3,(H,34,35) ODWSYLXRDSGQIO-UHFFFAOYSA-N 627358 (S,E)-1-(5-Chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methylbenzyl)-4-methylpiperazine-2-carboxylic acid::US20230331675, Compound 14 Programmed cell death 1 ligand/protein 1 Homo sapiens 85.2 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627358 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627358&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 165041256 485655753 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338709 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCCCCC#N)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C34H35N3O3/c1-25-21-29(24-37-19-8-6-15-32(37)34(38)39)33(40-20-9-3-7-18-35)22-28(25)17-16-27-13-10-14-30(31(27)23-36)26-11-4-2-5-12-26/h2,4-5,10-14,16-17,21-22,32H,3,6-9,15,19-20,24H2,1H3,(H,38,39) AUAUNIFEHADNSW-UHFFFAOYSA-N 627359 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(4-cyanobutoxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 15 Programmed cell death 1 ligand/protein 1 Homo sapiens 2.10 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627359&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005548 485655754 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338710 Cc1cc(CNCC(O)=O)c(OCCCCC#N)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C30H29N3O3/c1-22-17-26(20-33-21-30(34)35)29(36-16-7-3-6-15-31)18-25(22)14-13-24-11-8-12-27(28(24)19-32)23-9-4-2-5-10-23/h2,4-5,8-14,17-18,33H,3,6-7,16,20-21H2,1H3,(H,34,35) DAFRNPSUYGVYJH-UHFFFAOYSA-N 627360 (E)-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(4-cyanobutoxy)-5-methylbenzyl)glycine::US20230331675, Compound 16 Programmed cell death 1 ligand/protein 1 Homo sapiens 14.5 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627360&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005247 485655755 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338711 Cc1cc(CN2CCOC[C@H]2C(O)=O)c(OCCCCC#N)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C33H33N3O4/c1-24-19-28(22-36-16-18-39-23-31(36)33(37)38)32(40-17-7-3-6-15-34)20-27(24)14-13-26-11-8-12-29(30(26)21-35)25-9-4-2-5-10-25/h2,4-5,8-14,19-20,31H,3,6-7,16-18,22-23H2,1H3,(H,37,38) BNELSXAYTLHUFN-UHFFFAOYSA-N 627361 (S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(4-cyanobutoxy)-5-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 17 Programmed cell death 1 ligand/protein 1 Homo sapiens 4.40 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627361&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005550 485655756 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338712 Cc1cc(CN2CCNC[C@H]2C(O)=O)c(OCCCCC#N)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C33H34N4O3/c1-24-19-28(23-37-17-16-36-22-31(37)33(38)39)32(40-18-7-3-6-15-34)20-27(24)14-13-26-11-8-12-29(30(26)21-35)25-9-4-2-5-10-25/h2,4-5,8-14,19-20,31,36H,3,6-7,16-18,22-23H2,1H3,(H,38,39) SUAYPYIQIBEIGV-UHFFFAOYSA-N 627362 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(4-cyanobutoxy)-5-methylbenzyl)piperazine-2-carboxylic acid::US20230331675, Compound 18 Programmed cell death 1 ligand/protein 1 Homo sapiens 22.2 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627362&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163975851 485655757 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338713 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(Cl)cc1CNCC(O)=O InChI=1S/C25H21ClN2O2/c1-17-12-20(24(26)13-21(17)15-28-16-25(29)30)11-10-19-8-5-9-22(23(19)14-27)18-6-3-2-4-7-18/h2-13,28H,15-16H2,1H3,(H,29,30) WNDYQXMVSZEFDV-UHFFFAOYSA-N 627363 (E)-(5-Chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methylbenzyl)glycine::US20230331675, Compound 19 Programmed cell death 1 ligand/protein 1 Homo sapiens 6.20 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627363&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005541 485655758 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338714 OCc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H27F3N2O3/c31-30(32,33)27-16-23(18-35-14-5-4-11-28(35)29(37)38)24(19-36)15-22(27)13-12-21-9-6-10-25(26(21)17-34)20-7-2-1-3-8-20/h1-3,6-10,12-13,15-16,28,36H,4-5,11,14,18-19H2,(H,37,38) HOIPICGIYLBPDO-UHFFFAOYSA-N 627364 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-hydroxymethyl-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 20 Programmed cell death 1 ligand/protein 1 Homo sapiens 3.70 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627364&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005428 485655759 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338715 OCc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(cc1CN1CCOC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C29H25F3N2O4/c30-29(31,32)26-14-22(16-34-11-12-38-18-27(34)28(36)37)23(17-35)13-21(26)10-9-20-7-4-8-24(25(20)15-33)19-5-2-1-3-6-19/h1-10,13-14,27,35H,11-12,16-18H2,(H,36,37) BNAWAJUPKLJHJR-UHFFFAOYSA-N 627365 (S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-hydroxymethyl-5-trifluoromethylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 21 Programmed cell death 1 ligand/protein 1 Homo sapiens 57.6 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627365 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627365&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163459104 485655760 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338716 Cc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(Cl)cc1CN1CCOC[C@H]1C(O)=O InChI=1S/C28H28ClNO3/c1-19-15-23(26(29)16-24(19)17-30-13-14-33-18-27(30)28(31)32)12-11-21-9-6-10-25(20(21)2)22-7-4-3-5-8-22/h3-12,15-16,27H,13-14,17-18H2,1-2H3,(H,31,32) OKCJOFGEHFEXHW-UHFFFAOYSA-N 627366 (S,E)-4-(5-Chloro-2-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)morpholine-3-carboxylic acid::US20230331675, Compound 22 Programmed cell death 1 ligand/protein 1 Homo sapiens 11.4 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627366&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005482 485655761 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338717 Cc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(Cl)cc1CN1CCNC[C@H]1C(O)=O InChI=1S/C28H29ClN2O2/c1-19-15-23(26(29)16-24(19)18-31-14-13-30-17-27(31)28(32)33)12-11-21-9-6-10-25(20(21)2)22-7-4-3-5-8-22/h3-12,15-16,27,30H,13-14,17-18H2,1-2H3,(H,32,33) JLIRXSVSHRWZAT-UHFFFAOYSA-N 627367 (S,E)-1-(5-Chloro-2-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperazine-2-carboxylic acid::US20230331675, Compound 23 Programmed cell death 1 ligand/protein 1 Homo sapiens 186 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627367 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627367&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005480 485655762 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338718 COCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(C)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C32H34N2O4/c1-23-19-27(22-34-16-7-6-13-30(34)32(35)36)31(38-18-17-37-2)20-26(23)15-14-25-11-8-12-28(29(25)21-33)24-9-4-3-5-10-24/h3-5,8-12,14-15,19-20,30H,6-7,13,16-18,22H2,1-2H3,(H,35,36) OELXBHJIDMERQX-UHFFFAOYSA-N 627368 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-methoxyethoxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 24 Programmed cell death 1 ligand/protein 1 Homo sapiens 6.80 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627368 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627368&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005411 485655763 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338719 COCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(C)cc1CN1CCOC[C@H]1C(O)=O InChI=1S/C31H32N2O5/c1-22-17-26(20-33-13-14-37-21-29(33)31(34)35)30(38-16-15-36-2)18-25(22)12-11-24-9-6-10-27(28(24)19-32)23-7-4-3-5-8-23/h3-12,17-18,29H,13-16,20-21H2,1-2H3,(H,34,35) GVEKBPIMMZLQNY-UHFFFAOYSA-N 627369 (S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-methoxyethoxy)-5-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 25 Programmed cell death 1 ligand/protein 1 Homo sapiens 9.10 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627369 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627369&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005418 485655764 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338720 Cc1cc(CC2CCN[C@@H](C2)C(O)=O)c(OCCO)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C31H32N2O4/c1-21-16-26(17-22-12-13-33-29(18-22)31(35)36)30(37-15-14-34)19-25(21)11-10-24-8-5-9-27(28(24)20-32)23-6-3-2-4-7-23/h2-11,16,19,22,29,33-34H,12-15,17-18H2,1H3,(H,35,36) WKUFRAGINVFRJR-UHFFFAOYSA-N 627370 (S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-hydroxyethoxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 26 Programmed cell death 1 ligand/protein 1 Homo sapiens 4.70 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627370 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627370&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 168859742 485655765 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338721 COCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(C)cc1CN1CCNC[C@H]1C(O)=O InChI=1S/C31H33N3O4/c1-22-17-26(21-34-14-13-33-20-29(34)31(35)36)30(38-16-15-37-2)18-25(22)12-11-24-9-6-10-27(28(24)19-32)23-7-4-3-5-8-23/h3-12,17-18,29,33H,13-16,20-21H2,1-2H3,(H,35,36) DYYANHCTQOWSLM-UHFFFAOYSA-N 627371 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-methoxyethoxy)-5-methylbenzyl)piperazine-2-carboxylic acid::US20230331675, Compound 27 Programmed cell death 1 ligand/protein 1 Homo sapiens 57.2 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627371 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627371&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163538352 485655766 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338722 OCc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(cc1CN1CCNC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C29H26F3N3O3/c30-29(31,32)26-14-22(17-35-12-11-34-16-27(35)28(37)38)23(18-36)13-21(26)10-9-20-7-4-8-24(25(20)15-33)19-5-2-1-3-6-19/h1-10,13-14,27,34,36H,11-12,16-18H2,(H,37,38) HRVNPFSWKANOGX-UHFFFAOYSA-N 627372 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-hydroxymethyl-5-trifluoromethylbenzyl)piperazine-2-carboxylic acid::US20230331675, Compound 28 Programmed cell death 1 ligand/protein 1 Homo sapiens 135 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627372 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627372&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 164997061 485655767 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338723 Cc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(Cl)cc1CN1CCN(C[C@H]1C(O)=O)C(N)=O InChI=1S/C29H27ClN4O3/c1-19-14-22(11-10-21-8-5-9-24(25(21)16-31)20-6-3-2-4-7-20)26(30)15-23(19)17-33-12-13-34(29(32)37)18-27(33)28(35)36/h2-11,14-15,27H,12-13,17-18H2,1H3,(H2,32,37)(H,35,36) XTSZADSINYMKAN-UHFFFAOYSA-N 627373 (S,E)-4-Carbamoyl-1-(5-chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methylbenzyl)piperazine-2-carboxylic acid::US20230331675, Compound 29 Programmed cell death 1 ligand/protein 1 Homo sapiens 62.0 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627373 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627373&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005371 485655768 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338724 Cc1cc(CN2CCOC[C@H]2C(O)=O)c(OCCO)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C30H30N2O5/c1-21-16-25(19-32-12-14-36-20-28(32)30(34)35)29(37-15-13-33)17-24(21)11-10-23-8-5-9-26(27(23)18-31)22-6-3-2-4-7-22/h2-11,16-17,28,33H,12-15,19-20H2,1H3,(H,34,35) VZSZDPSFAKIPTK-UHFFFAOYSA-N 627374 (S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-hydroxyethoxy)-5-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 30 Programmed cell death 1 ligand/protein 1 Homo sapiens 7.70 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627374&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005245 485655769 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338725 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(O)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C29H28N2O3/c1-20-16-24(19-31-15-6-5-12-27(31)29(33)34)28(32)17-23(20)14-13-22-10-7-11-25(26(22)18-30)21-8-3-2-4-9-21/h2-4,7-11,13-14,16-17,27,32H,5-6,12,15,19H2,1H3,(H,33,34) SAKRVTRHBYXNIX-UHFFFAOYSA-N 627375 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-hydroxy-5-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 31 Programmed cell death 1 ligand/protein 1 Homo sapiens 1160 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627375 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627375&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005408 485655770 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338726 COCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(CN[C@@](C)(CO)C(O)=O)cc1Cl InChI=1S/C29H29ClN2O5/c1-29(19-33,28(34)35)32-18-23-15-26(30)27(37-14-13-36-2)16-22(23)12-11-21-9-6-10-24(25(21)17-31)20-7-4-3-5-8-20/h3-12,15-16,32-33H,13-14,18-19H2,1-2H3,(H,34,35) NJBJJRLITHCELY-UHFFFAOYSA-N 627376 (S,E)-2-((5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(2-methoxyethoxy)benzyl)amino)-3-hydroxy-2-methylpropanoic acid::US20230331675, Compound 35 Programmed cell death 1 ligand/protein 1 Homo sapiens 1147 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627376 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627376&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 168859738 485655771 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338727 CS(=O)(=O)CCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(CN[C@@H](CO)C(O)=O)cc1Cl |r| InChI=1S/C29H29ClN2O6S/c1-39(36,37)14-6-13-38-28-16-22(23(15-26(28)30)18-32-27(19-33)29(34)35)12-11-21-9-5-10-24(25(21)17-31)20-7-3-2-4-8-20/h2-5,7-12,15-16,27,32-33H,6,13-14,18-19H2,1H3,(H,34,35) HRNLFMMHXZMBBK-UHFFFAOYSA-N 627377 (S,E)-2-((5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(3-methylsulfonyl)propoxy)benzyl)amino)-3-hydroxy-2-methylpropionic acid::US20230331675, Compound 38 Programmed cell death 1 ligand/protein 1 Homo sapiens 298 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627377 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627377&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005467 485655772 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338728 Cc1cc(OCCCCC#N)c(CN2CCCC[C@H]2C(O)=O)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C34H35N3O3/c1-25-21-33(40-20-9-3-7-18-35)29(24-37-19-8-6-15-32(37)34(38)39)22-28(25)17-16-27-13-10-14-30(31(27)23-36)26-11-4-2-5-12-26/h2,4-5,10-14,16-17,21-22,32H,3,6-9,15,19-20,24H2,1H3,(H,38,39) YGMLHRDBUQRKFY-UHFFFAOYSA-N 627378 (S,E)-1-(5-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(4-cyanobutoxy)-4-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 39 Programmed cell death 1 ligand/protein 1 Homo sapiens 172 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627378 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627378&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005472 485655773 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338729 Cc1cc(OCCCCC#N)c(CN2CCOC[C@H]2C(O)=O)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C33H33N3O4/c1-24-19-32(40-17-7-3-6-15-34)28(22-36-16-18-39-23-31(36)33(37)38)20-27(24)14-13-26-11-8-12-29(30(26)21-35)25-9-4-2-5-10-25/h2,4-5,8-14,19-20,31H,3,6-7,16-18,22-23H2,1H3,(H,37,38) WPJHIGIQKPLIGX-UHFFFAOYSA-N 627379 (S,E)-4-(5-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(4-cyanobutoxy)-4-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 40 Programmed cell death 1 ligand/protein 1 Homo sapiens 1437 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627379 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627379&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005473 485655774 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338730 Cc1cc(OCCO)c(CN2CCCC[C@H]2C(O)=O)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C31H32N2O4/c1-22-18-30(37-17-16-34)26(21-33-15-6-5-12-29(33)31(35)36)19-25(22)14-13-24-10-7-11-27(28(24)20-32)23-8-3-2-4-9-23/h2-4,7-11,13-14,18-19,29,34H,5-6,12,15-17,21H2,1H3,(H,35,36) OPXWQFOLNBCOSD-UHFFFAOYSA-N 627380 (S,E)-1-(5-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-hydroxyethoxy)-4-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 41 Programmed cell death 1 ligand/protein 1 Homo sapiens 281 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627380&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005469 485655775 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338731 Cc1cc(OCCO)c(CN2CCOC[C@H]2C(O)=O)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C30H30N2O5/c1-21-16-29(37-15-13-33)25(19-32-12-14-36-20-28(32)30(34)35)17-24(21)11-10-23-8-5-9-26(27(23)18-31)22-6-3-2-4-7-22/h2-11,16-17,28,33H,12-15,19-20H2,1H3,(H,34,35) JLEAKFTUWIMTBU-UHFFFAOYSA-N 627381 (S,E)-4-(5-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-hydroxyethoxy)-4-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 42 Programmed cell death 1 ligand/protein 1 Homo sapiens 706 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627381 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627381&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005566 485655776 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338732 COCCOc1cc(C)c(\C=C\c2cccc(-c3ccccc3)c2C#N)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C32H34N2O4/c1-23-19-31(38-18-17-37-2)27(22-34-16-7-6-13-30(34)32(35)36)20-26(23)15-14-25-11-8-12-28(29(25)21-33)24-9-4-3-5-10-24/h3-5,8-12,14-15,19-20,30H,6-7,13,16-18,22H2,1-2H3,(H,35,36) DUAGTAAHNWYMQA-UHFFFAOYSA-N 627382 (S,E)-1-(5-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-methoxyethoxy)-4-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 43 Programmed cell death 1 ligand/protein 1 Homo sapiens 83.9 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627382 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627382&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005576 485655777 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338733 COCCOc1cc(C)c(\C=C\c2cccc(-c3ccccc3)c2C#N)cc1CN1CCOC[C@H]1C(O)=O InChI=1S/C31H32N2O5/c1-22-17-30(38-16-15-36-2)26(20-33-13-14-37-21-29(33)31(34)35)18-25(22)12-11-24-9-6-10-27(28(24)19-32)23-7-4-3-5-8-23/h3-12,17-18,29H,13-16,20-21H2,1-2H3,(H,34,35) VIFNQRJGBZWVIR-UHFFFAOYSA-N 627383 (S,E)-4-(5-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(2-methoxyethoxy)-4-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 44 Programmed cell death 1 ligand/protein 1 Homo sapiens 265 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627383 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627383&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005468 485655778 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338734 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCC#N)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C31H29N3O3/c1-22-18-26(21-34-16-6-5-12-29(34)31(35)36)30(37-17-15-32)19-25(22)14-13-24-10-7-11-27(28(24)20-33)23-8-3-2-4-9-23/h2-4,7-11,13-14,18-19,29H,5-6,12,16-17,21H2,1H3,(H,35,36) BODAWVIJZJJUFP-UHFFFAOYSA-N 627384 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(cyanomethoxy)-5-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 48 Programmed cell death 1 ligand/protein 1 Homo sapiens 8.00 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627384 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627384&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005474 485655779 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338735 COCc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C31H29F3N2O3/c1-39-20-25-16-23(14-13-22-10-7-11-26(27(22)18-35)21-8-3-2-4-9-21)28(31(32,33)34)17-24(25)19-36-15-6-5-12-29(36)30(37)38/h2-4,7-11,13-14,16-17,29H,5-6,12,15,19-20H2,1H3,(H,37,38) WLHWVJZUPNXHMV-UHFFFAOYSA-N 627385 (S,E)-1-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(methoxymethyl)-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 49 Programmed cell death 1 ligand/protein 1 Homo sapiens 18.6 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627385 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627385&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005268 485655780 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338736 COCc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(cc1CN1CCOC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H27F3N2O4/c1-38-18-24-14-22(11-10-21-8-5-9-25(26(21)16-34)20-6-3-2-4-7-20)27(30(31,32)33)15-23(24)17-35-12-13-39-19-28(35)29(36)37/h2-11,14-15,28H,12-13,17-19H2,1H3,(H,36,37) UNUGVCKLVDGZOW-UHFFFAOYSA-N 627386 US20230331675, Compound 50::US20230331675, Compound 54::(S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(methoxymethyl)-5-trifluoromethylbenzyl)morpholine-3-carboxylic acid Programmed cell death 1 ligand/protein 1 Homo sapiens 141 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627386 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627386&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005490 485655781 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338737 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F |r| InChI=1S/C30H30F3NO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(37-2)24(17-26(23)30(31,32)33)19-34-16-7-6-13-27(34)29(35)36/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,35,36) OMRMLTBTDTUNFN-UHFFFAOYSA-N 627387 (S,E)-1-(2-Methoxy-4-(2-(2-methyl-d3)-[1,1'-biphenyl]-3-yl)vinyl)-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 51 Programmed cell death 1 ligand/protein 1 Homo sapiens 2.20 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627387 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627387&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005277 485655782 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338738 COCc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(cc1CN1CCOC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H27F3N2O4/c1-38-18-24-14-22(11-10-21-8-5-9-25(26(21)16-34)20-6-3-2-4-7-20)27(30(31,32)33)15-23(24)17-35-12-13-39-19-28(35)29(36)37/h2-11,14-15,28H,12-13,17-19H2,1H3,(H,36,37) UNUGVCKLVDGZOW-UHFFFAOYSA-N 627386 US20230331675, Compound 50::US20230331675, Compound 54::(S,E)-4-(4-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-(methoxymethyl)-5-trifluoromethylbenzyl)morpholine-3-carboxylic acid Programmed cell death 1 ligand/protein 1 Homo sapiens 160 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627386 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627386&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005490 485655781 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338739 Cc1c(\C=C\c2cc(CN[C@@](C)(CO)C(O)=O)ccc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C27H26F3NO3/c1-18-20(9-6-10-23(18)21-7-4-3-5-8-21)12-13-22-15-19(11-14-24(22)27(28,29)30)16-31-26(2,17-32)25(33)34/h3-15,31-32H,16-17H2,1-2H3,(H,33,34) ITARRJJJADSSAW-UHFFFAOYSA-N 560589 US11384048, Compound 29::US20230331675, Compound 55 Programmed cell death 1 ligand/protein 1 Homo sapiens 29.5 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=560589 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=560589&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 147980044 472622182 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338740 COc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(Cl)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C29H27ClN2O3/c1-35-28-17-22(26(30)16-23(28)19-32-15-6-5-12-27(32)29(33)34)14-13-21-10-7-11-24(25(21)18-31)20-8-3-2-4-9-20/h2-4,7-11,13-14,16-17,27H,5-6,12,15,19H2,1H3,(H,33,34) DLUHCNOPTRIJJK-UHFFFAOYSA-N 627390 (S,E)-1-(5-Chloro-4-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxybenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 57 Programmed cell death 1 ligand/protein 1 Homo sapiens 4.40 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627390 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627390&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005358 485655784 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338741 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(Cl)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C29H30ClNO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(34-2)24(17-26(23)30)19-31-16-7-6-13-27(31)29(32)33/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,32,33) LEKIWXXXRQSDSA-UHFFFAOYSA-N 627391 US20230331675, Compound 58::US20230331675, Compound 59::(S,E)-1-(5-Chloro-2-methoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid Programmed cell death 1 ligand/protein 1 Homo sapiens 6.80 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627391 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627391&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163736894 485655785 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338742 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(Cl)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C29H30ClNO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(34-2)24(17-26(23)30)19-31-16-7-6-13-27(31)29(32)33/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,32,33) LEKIWXXXRQSDSA-UHFFFAOYSA-N 627391 US20230331675, Compound 58::US20230331675, Compound 59::(S,E)-1-(5-Chloro-2-methoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid Programmed cell death 1 ligand/protein 1 Homo sapiens 8.90 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627391 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627391&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163736894 485655785 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338743 COCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(CN2CCCC[C@H]2C(O)=O)cc1Cl InChI=1S/C31H31ClN2O4/c1-37-16-17-38-30-19-24(25(18-28(30)32)21-34-15-6-5-12-29(34)31(35)36)14-13-23-10-7-11-26(27(23)20-33)22-8-3-2-4-9-22/h2-4,7-11,13-14,18-19,29H,5-6,12,15-17,21H2,1H3,(H,35,36) YMGIPMZVWNUWPJ-UHFFFAOYSA-N 627393 (S,E)-1-(5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(2-methoxyethoxy)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 33 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627393 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627393&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005552 485655786 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338744 COCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(CN2CCOC[C@H]2C(O)=O)cc1Cl InChI=1S/C30H29ClN2O5/c1-36-14-15-38-29-17-23(24(16-27(29)31)19-33-12-13-37-20-28(33)30(34)35)11-10-22-8-5-9-25(26(22)18-32)21-6-3-2-4-7-21/h2-11,16-17,28H,12-15,19-20H2,1H3,(H,34,35) WFBZHYNPEDUBQC-UHFFFAOYSA-N 627394 (S,E)-4-(5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(2-methoxyethoxy)benzyl)morpholine-3-carboxylic acid::US20230331675, Compound 34 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627394 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627394&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 165087929 485655787 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338745 CS(=O)(=O)OCCOc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(CN2CCCC[C@H]2C(O)=O)cc1Cl |r| InChI=1S/C31H31ClN2O6S/c1-41(37,38)40-17-16-39-30-19-24(25(18-28(30)32)21-34-15-6-5-12-29(34)31(35)36)14-13-23-10-7-11-26(27(23)20-33)22-8-3-2-4-9-22/h2-4,7-11,13-14,18-19,29H,5-6,12,15-17,21H2,1H3,(H,35,36) CQVFKRFNYUXJBW-UHFFFAOYSA-N 627395 (S,E)-1-(5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(3-methylsulfonyl)propoxy)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 36 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627395 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627395&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 169298527 485655788 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338746 CCCC(Oc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(CN2CCOC[C@H]2C(O)=O)cc1Cl)S(C)(=O)=O InChI=1S/C32H33ClN2O6S/c1-3-8-31(42(2,38)39)41-30-18-24(25(17-28(30)33)20-35-15-16-40-21-29(35)32(36)37)14-13-23-11-7-12-26(27(23)19-34)22-9-5-4-6-10-22/h4-7,9-14,17-18,29,31H,3,8,15-16,20-21H2,1-2H3,(H,36,37) RJHNUYKPGJLDKZ-UHFFFAOYSA-N 627396 (S,E)-4-(5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(3-methylmethylsulfonyl)propoxy)benzyl)morpholine-3-carboxylic acid::US20230331675, Compound 37 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627396&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 169489762 485655789 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338747 Cc1ccc(OCCCCC#N)c(CN2CCCC[C@H]2C(O)=O)c1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C34H35N3O3/c1-25-16-19-33(40-22-9-3-7-20-35)31(24-37-21-8-6-15-32(37)34(38)39)28(25)18-17-27-13-10-14-29(30(27)23-36)26-11-4-2-5-12-26/h2,4-5,10-14,16-19,32H,3,6-9,15,21-22,24H2,1H3,(H,38,39) UYVWXNRXMKAGFO-UHFFFAOYSA-N 627397 (S,E)-1-(2-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-6-(4-cyanobutoxy)-3-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 45 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627397&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005241 485655790 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338748 Cc1ccc(OCCCCC#N)c(CN2CCOC[C@H]2C(O)=O)c1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C33H33N3O4/c1-24-13-16-32(40-19-7-3-6-17-34)30(22-36-18-20-39-23-31(36)33(37)38)27(24)15-14-26-11-8-12-28(29(26)21-35)25-9-4-2-5-10-25/h2,4-5,8-16,31H,3,6-7,18-20,22-23H2,1H3,(H,37,38) HFOJPSFNDGKPBE-UHFFFAOYSA-N 627398 (S,E)-4-(2-(2-(2-Cyano-[1,1'-biphenyl]-3-yl)vinyl)-6-(4-cyanobutoxy)-3-methylbenzyl)morpholine-3-carboxylic acid::US20230331675, Compound 46 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627398&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 168859736 485655791 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338749 OC(=O)[C@@H]1CCCCN1Cc1cc(Cl)c(OCC#N)cc1\C=C\c1cccc(-c2ccccc2)c1C#N InChI=1S/C30H26ClN3O3/c31-27-17-24(20-34-15-5-4-11-28(34)30(35)36)23(18-29(27)37-16-14-32)13-12-22-9-6-10-25(26(22)19-33)21-7-2-1-3-8-21/h1-3,6-10,12-13,17-18,28H,4-5,11,15-16,20H2,(H,35,36) YCWREHCNXFHVRN-UHFFFAOYSA-N 627399 (S,E)-1-(5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(cyanomethoxy)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 47 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627399 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627399&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005486 485655792 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338750 COc1cc(\C=C\c2cccc(-c3ccccc3)c2C#N)c(CN2CCCC[C@H]2C(O)=O)cc1Cl InChI=1S/C29H27ClN2O3/c1-35-28-17-22(23(16-26(28)30)19-32-15-6-5-12-27(32)29(33)34)14-13-21-10-7-11-24(25(21)18-31)20-8-3-2-4-9-20/h2-4,7-11,13-14,16-17,27H,5-6,12,15,19H2,1H3,(H,33,34) WVOCYDGFIJQLKW-UHFFFAOYSA-N 627400 (S,E)-1-(5-Chloro-2-(2-(2-cyano-[1,1'-biphenyl]-3-yl)vinyl)-4-(methoxy-d3) benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 52 Programmed cell death 1 ligand/protein 1 Homo sapiens >10000 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627400 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627400&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 169489763 485655793 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338751 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H30F3NO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(37-2)24(17-26(23)30(31,32)33)19-34-16-7-6-13-27(34)29(35)36/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,35,36) OMRMLTBTDTUNFN-UHFFFAOYSA-N 627350 US20230331675, Compound 6::(S,E)-1-(2-Methoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 61::US20230331675, Compound 72::US20230331675, Compound 60 Programmed cell death 1 ligand/protein 1 Homo sapiens 0.590 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627350&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005277 485655745 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338752 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H30F3NO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(37-2)24(17-26(23)30(31,32)33)19-34-16-7-6-13-27(34)29(35)36/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,35,36) OMRMLTBTDTUNFN-UHFFFAOYSA-N 627350 US20230331675, Compound 6::(S,E)-1-(2-Methoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 61::US20230331675, Compound 72::US20230331675, Compound 60 Programmed cell death 1 ligand/protein 1 Homo sapiens 0.730 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627350&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005277 485655745 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338753 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@@H]1C(O)=O)C(F)(F)F InChI=1S/C30H30F3NO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(37-2)24(17-26(23)30(31,32)33)19-34-16-7-6-13-27(34)29(35)36/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,35,36) OMRMLTBTDTUNFN-UHFFFAOYSA-N 627403 (R,E)-1-(2-Methoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 62 Programmed cell death 1 ligand/protein 1 Homo sapiens 7.42 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627403&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005288 485655794 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338754 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(OC)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C30H33NO4/c1-21-22(12-9-13-26(21)23-10-5-4-6-11-23)15-16-24-18-29(35-3)25(19-28(24)34-2)20-31-17-8-7-14-27(31)30(32)33/h4-6,9-13,15-16,18-19,27H,7-8,14,17,20H2,1-3H3,(H,32,33) NSLKMRONVGCNTR-UHFFFAOYSA-N 627404 (S,E)-1-(2,5-Dimethoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 63 Programmed cell death 1 ligand/protein 1 Homo sapiens 30.5 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627404&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005549 485655795 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338755 COc1cc(\C(F)=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H29F4NO3/c1-19-21(11-8-12-23(19)20-9-4-3-5-10-20)16-26(31)24-17-28(38-2)22(15-25(24)30(32,33)34)18-35-14-7-6-13-27(35)29(36)37/h3-5,8-12,15-17,27H,6-7,13-14,18H2,1-2H3,(H,36,37) NWFBZNBXVANLDC-UHFFFAOYSA-N 627405 (S,Z)-1-(4-(1-Fluoro-2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)2-methoxy-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 64 Programmed cell death 1 ligand/protein 1 Homo sapiens 29.5 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627405&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005429 485655796 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338756 COc1cc(\C(F)=C\c2cccc(c2C)-c2ccccc2)c(cc1CNCCO)C(F)(F)F InChI=1S/C26H25F4NO2/c1-17-19(9-6-10-21(17)18-7-4-3-5-8-18)14-24(27)22-15-25(33-2)20(16-31-11-12-32)13-23(22)26(28,29)30/h3-10,13-15,31-32H,11-12,16H2,1-2H3 KKLHYPDTQZZEBM-UHFFFAOYSA-N 627406 (Z)-2-((4-(1-Fluoro-2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)amino)-1-ethanol::US20230331675, Compound 65 Programmed cell death 1 ligand/protein 1 Homo sapiens 48.0 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627406&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 165015925 485655797 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338757 COc1cc(\C(Br)=C\c2cccc(c2C)-c2ccccc2)c(cc1CNCCO)C(F)(F)F InChI=1S/C26H25BrF3NO2/c1-17-19(9-6-10-21(17)18-7-4-3-5-8-18)14-24(27)22-15-25(33-2)20(16-31-11-12-32)13-23(22)26(28,29)30/h3-10,13-15,31-32H,11-12,16H2,1-2H3 OQHQRTYHRAVLGC-UHFFFAOYSA-N 627407 (Z)-2-((4-(1-Bromo-2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)amino)-1-ethanol::US20230331675, Compound 66 Programmed cell death 1 ligand/protein 1 Homo sapiens 41.7 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627407 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627407&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005282 485655798 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338758 COc1cc(\C(Br)=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H29BrF3NO3/c1-19-21(11-8-12-23(19)20-9-4-3-5-10-20)16-26(31)24-17-28(38-2)22(15-25(24)30(32,33)34)18-35-14-7-6-13-27(35)29(36)37/h3-5,8-12,15-17,27H,6-7,13-14,18H2,1-2H3,(H,36,37) KRZPEHDSXLASQW-UHFFFAOYSA-N 627408 (S,Z)-1-(4-(1-Bromo-2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 67 Programmed cell death 1 ligand/protein 1 Homo sapiens 12.8 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627408&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163721496 485655799 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338759 COc1cc(\C=C(/Br)c2cccc(c2C)-c2ccccc2)c(C)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C30H32BrNO3/c1-20-16-24(19-32-15-8-7-14-28(32)30(33)34)29(35-3)18-23(20)17-27(31)26-13-9-12-25(21(26)2)22-10-5-4-6-11-22/h4-6,9-13,16-18,28H,7-8,14-15,19H2,1-3H3,(H,33,34) YBYXYCRCXLNFSC-UHFFFAOYSA-N 627409 (S,Z)-1-(4-(2-Bromo-2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-methylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 68 Programmed cell death 1 ligand/protein 1 Homo sapiens 169 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627409 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627409&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005440 485655800 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338760 COc1cc(\C=C(/Br)c2cccc(c2C)-c2ccccc2)c(C)cc1CNCCO InChI=1S/C26H28BrNO2/c1-18-14-22(17-28-12-13-29)26(30-3)16-21(18)15-25(27)24-11-7-10-23(19(24)2)20-8-5-4-6-9-20/h4-11,14-16,28-29H,12-13,17H2,1-3H3 RDDPJSKZMUTPMU-UHFFFAOYSA-N 627410 (Z)-2-((4-(2-Bromo-2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-methylbenzyl)amino)-1-ethanol::US20230331675, Compound 69 Programmed cell death 1 ligand/protein 1 Homo sapiens 260 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627410 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627410&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163924316 485655801 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338761 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(C)cc1CN1CCCC[C@H]1C(O)=O InChI=1S/C30H33NO3/c1-21-18-26(20-31-17-8-7-14-28(31)30(32)33)29(34-3)19-25(21)16-15-23-12-9-13-27(22(23)2)24-10-5-4-6-11-24/h4-6,9-13,15-16,18-19,28H,7-8,14,17,20H2,1-3H3,(H,32,33) ZAYVLSMZKZTRDN-UHFFFAOYSA-N 627411 (S,E)-1-(2-Methoxy-5-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 70 Programmed cell death 1 ligand/protein 1 Homo sapiens 9.31 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627411 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627411&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005569 485655802 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338762 COc1cc(\C=C\c2cccc(c2Cl)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C29H27ClF3NO3/c1-37-26-17-21(14-13-20-10-7-11-23(27(20)30)19-8-3-2-4-9-19)24(29(31,32)33)16-22(26)18-34-15-6-5-12-25(34)28(35)36/h2-4,7-11,13-14,16-17,25H,5-6,12,15,18H2,1H3,(H,35,36) XZBRGQWVNIYJPP-UHFFFAOYSA-N 627412 (S,E)-1-(4-(2-(2-Chloro-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 71 Programmed cell death 1 ligand/protein 1 Homo sapiens 0.680 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627412 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627412&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 164113497 485655803 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338763 COc1cc(\C=C\c2cccc(c2C)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H30F3NO3/c1-20-21(11-8-12-25(20)22-9-4-3-5-10-22)14-15-23-18-28(37-2)24(17-26(23)30(31,32)33)19-34-16-7-6-13-27(34)29(35)36/h3-5,8-12,14-15,17-18,27H,6-7,13,16,19H2,1-2H3,(H,35,36) OMRMLTBTDTUNFN-UHFFFAOYSA-N 627350 US20230331675, Compound 6::(S,E)-1-(2-Methoxy-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 61::US20230331675, Compound 72::US20230331675, Compound 60 Programmed cell death 1 ligand/protein 1 Homo sapiens 2.00 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627350&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005277 485655745 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338764 COc1cc(\C=C\c2cccc(c2CF)-c2ccccc2)c(cc1CN1CCCC[C@H]1C(O)=O)C(F)(F)F InChI=1S/C30H29F4NO3/c1-38-28-17-22(14-13-21-10-7-11-24(25(21)18-31)20-8-3-2-4-9-20)26(30(32,33)34)16-23(28)19-35-15-6-5-12-27(35)29(36)37/h2-4,7-11,13-14,16-17,27H,5-6,12,15,18-19H2,1H3,(H,36,37) PMYGAEFEWAWKCB-UHFFFAOYSA-N 627414 (S,E)-1-(4-(2-(2-Fluoromethyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)piperidine-2-carboxylic acid::US20230331675, Compound 73 Programmed cell death 1 ligand/protein 1 Homo sapiens 3.99 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627414&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005386 485655804 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338765 COc1cc(\C=C\c2cccc(c2CF)-c2ccccc2)c(cc1CNCCO)C(F)(F)F InChI=1S/C26H25F4NO2/c1-33-25-15-20(24(26(28,29)30)14-21(25)17-31-12-13-32)11-10-19-8-5-9-22(23(19)16-27)18-6-3-2-4-7-18/h2-11,14-15,31-32H,12-13,16-17H2,1H3 YKMBFERCMVGJPF-UHFFFAOYSA-N 627415 (E)-2-((4-(2-(2-Fluoromethyl-[1,1'-biphenyl]-3-yl)vinyl)-2-methoxy-5-trifluoromethylbenzyl)amino)-1-ethanol::US20230331675, Compound 74 Programmed cell death 1 ligand/protein 1 Homo sapiens 7.09 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627415&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 167005406 485655805 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338766 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2cccc(I)c2)cc1\C=C\c1cccc(c1C)-c1ccccc1 |r| InChI=1S/C36H36INO3/c1-25-20-31(23-38-19-7-6-16-34(38)36(39)40)35(41-24-27-10-8-14-32(37)21-27)22-30(25)18-17-28-13-9-15-33(26(28)2)29-11-4-3-5-12-29/h3-5,8-15,17-18,20-22,34H,6-7,16,19,23-24H2,1-2H3,(H,39,40) XNRJPEHWVVSHPD-UHFFFAOYSA-N 627416 (S,E)-1-(2-((3-Iodobenzyloxy)-5-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 75 Programmed cell death 1 ligand/protein 1 Homo sapiens 28.4 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627416&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 169298538 485655806 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338767 Cc1c(\C=C\c2cc(OCc3cccc(I)c3)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 |r| InChI=1S/C36H33F3INO3/c1-24-26(12-8-14-31(24)27-10-3-2-4-11-27)16-17-28-21-34(44-23-25-9-7-13-30(40)19-25)29(20-32(28)36(37,38)39)22-41-18-6-5-15-33(41)35(42)43/h2-4,7-14,16-17,19-21,33H,5-6,15,18,22-23H2,1H3,(H,42,43) AJIQNYBBFDJSPD-UHFFFAOYSA-N 627417 (S,E)-1-(2-((3-Iodobenzyloxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 77 Programmed cell death 1 ligand/protein 1 Homo sapiens 5.91 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627417&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 169489764 485655807 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338768 Cc1c(\C=C\c2cc(OCc3ccc(I)cc3)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 |r| InChI=1S/C36H33F3INO3/c1-24-26(10-7-11-31(24)27-8-3-2-4-9-27)15-16-28-21-34(44-23-25-13-17-30(40)18-14-25)29(20-32(28)36(37,38)39)22-41-19-6-5-12-33(41)35(42)43/h2-4,7-11,13-18,20-21,33H,5-6,12,19,22-23H2,1H3,(H,42,43) RBCISNUOLYJMGD-UHFFFAOYSA-N 627418 (S,E)-1-(2-((4-Iodobenzyloxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 78 Programmed cell death 1 ligand/protein 1 Homo sapiens 65.5 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627418&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 169489765 485655808 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338769 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCc2cc(I)ccn2)cc1\C=C\c1cccc(c1C)-c1ccccc1 InChI=1S/C35H35IN2O3/c1-24-19-29(22-38-18-7-6-13-33(38)35(39)40)34(41-23-31-21-30(36)16-17-37-31)20-28(24)15-14-26-11-8-12-32(25(26)2)27-9-4-3-5-10-27/h3-5,8-12,14-17,19-21,33H,6-7,13,18,22-23H2,1-2H3,(H,39,40) QOABCIOVJXVTRU-UHFFFAOYSA-N 627419 (S,E)-1-(2-((4-Iodo-pyridin-2-yl)methoxy)-5-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 79 Programmed cell death 1 ligand/protein 1 Homo sapiens 5.31 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627419&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163906069 485655809 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338770 Cc1c(\C=C\c2cc(OCc3cc(I)ccn3)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C35H32F3IN2O3/c1-23-24(10-7-11-30(23)25-8-3-2-4-9-25)13-14-26-19-33(44-22-29-20-28(39)15-16-40-29)27(18-31(26)35(36,37)38)21-41-17-6-5-12-32(41)34(42)43/h2-4,7-11,13-16,18-20,32H,5-6,12,17,21-22H2,1H3,(H,42,43) TZUCDKPJSXVLJF-UHFFFAOYSA-N 627420 (S,E)-1-(2-((4-Iodopyridin-2-yl)methoxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 80 Programmed cell death 1 ligand/protein 1 Homo sapiens 3.97 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627420&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163990030 485655810 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338771 Cc1c(\C=C\c2cc(OCc3ccnc(I)c3)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C35H32F3IN2O3/c1-23-25(10-7-11-29(23)26-8-3-2-4-9-26)13-14-27-20-32(44-22-24-15-16-40-33(39)18-24)28(19-30(27)35(36,37)38)21-41-17-6-5-12-31(41)34(42)43/h2-4,7-11,13-16,18-20,31H,5-6,12,17,21-22H2,1H3,(H,42,43) AZBWNCKYKMAUKY-UHFFFAOYSA-N 627421 (S,E)-1-(2-((2-Iodopyridin-4-yl)methoxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 81 Programmed cell death 1 ligand/protein 1 Homo sapiens 2.13 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627421&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163441667 485655811 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338772 Cc1c(\C=C\c2cc(OCc3cncc(I)c3)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C35H32F3IN2O3/c1-23-25(10-7-11-30(23)26-8-3-2-4-9-26)13-14-27-18-33(44-22-24-16-29(39)20-40-19-24)28(17-31(27)35(36,37)38)21-41-15-6-5-12-32(41)34(42)43/h2-4,7-11,13-14,16-20,32H,5-6,12,15,21-22H2,1H3,(H,42,43) DVFPFOJQIFIMIZ-UHFFFAOYSA-N 627422 (S,E)-1-(2-((5-Iodopyridin-3-yl)methoxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 82 Programmed cell death 1 ligand/protein 1 Homo sapiens 1.85 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627422&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163533800 485655812 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338773 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCCCCF)cc1\C=C\c1cccc(c1C)-c1ccccc1 InChI=1S/C33H38FNO3/c1-24-21-29(23-35-19-8-6-15-31(35)33(36)37)32(38-20-9-7-18-34)22-28(24)17-16-26-13-10-14-30(25(26)2)27-11-4-3-5-12-27/h3-5,10-14,16-17,21-22,31H,6-9,15,18-20,23H2,1-2H3,(H,36,37) MDGXQHAIQZGTDM-UHFFFAOYSA-N 627423 (S,E)-1-(2-(4-Fluorobutoxy)-5-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 83 Programmed cell death 1 ligand/protein 1 Homo sapiens 6.99 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627423&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163767118 485655813 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338774 Cc1cc(CN2CCCC[C@H]2C(O)=O)c(OCCCF)cc1\C=C\c1cccc(c1C)-c1ccccc1 InChI=1S/C32H36FNO3/c1-23-20-28(22-34-18-7-6-14-30(34)32(35)36)31(37-19-9-17-33)21-27(23)16-15-25-12-8-13-29(24(25)2)26-10-4-3-5-11-26/h3-5,8,10-13,15-16,20-21,30H,6-7,9,14,17-19,22H2,1-2H3,(H,35,36) ITRGDRRMHRXSDN-UHFFFAOYSA-N 627424 (S,E)-1-(2-(3-Fluoropropoxy)-5-methyl-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 84 Programmed cell death 1 ligand/protein 1 Homo sapiens 8.03 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627424&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163660118 485655814 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338775 Cc1c(\C=C\c2cc(OCCCCF)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C33H35F4NO3/c1-23-24(12-9-13-28(23)25-10-3-2-4-11-25)15-16-26-21-31(41-19-8-6-17-34)27(20-29(26)33(35,36)37)22-38-18-7-5-14-30(38)32(39)40/h2-4,9-13,15-16,20-21,30H,5-8,14,17-19,22H2,1H3,(H,39,40) HLMNDXLIIUKNLX-UHFFFAOYSA-N 627426 (S,E)-1-(2-(4-Fluorobutoxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 85 Programmed cell death 1 ligand/protein 1 Homo sapiens 4.34 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627426&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163617829 485655815 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338776 Cc1c(\C=C\c2cc(OCCCF)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C32H33F4NO3/c1-22-23(11-7-12-27(22)24-9-3-2-4-10-24)14-15-25-20-30(40-18-8-16-33)26(19-28(25)32(34,35)36)21-37-17-6-5-13-29(37)31(38)39/h2-4,7,9-12,14-15,19-20,29H,5-6,8,13,16-18,21H2,1H3,(H,38,39) WGXSEJARNZHDBJ-UHFFFAOYSA-N 627427 (S,E)-1-(2-(3-Fluoropropoxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 86 Programmed cell death 1 ligand/protein 1 Homo sapiens 3.58 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627427&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 164061059 485655816 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89 1338777 Cc1c(\C=C\c2cc(OCCF)c(CN3CCCC[C@H]3C(O)=O)cc2C(F)(F)F)cccc1-c1ccccc1 InChI=1S/C31H31F4NO3/c1-21-22(10-7-11-26(21)23-8-3-2-4-9-23)13-14-24-19-29(39-17-15-32)25(18-27(24)31(33,34)35)20-36-16-6-5-12-28(36)30(37)38/h2-4,7-11,13-14,18-19,28H,5-6,12,15-17,20H2,1H3,(H,37,38) FOTFAIHPVVVYKJ-UHFFFAOYSA-N 627428 (S,E)-1-(2-(2-Fluoroethoxy)-4-(2-(2-methyl-[1,1'-biphenyl]-3-yl)vinyl)-5-(trifluoromethyl)benzyl)piperidine-2-carboxylic acid::US20230331675, Compound 87 Programmed cell death 1 ligand/protein 1 Homo sapiens 2.80 US Patent 10.7270/Q20G3Q99 aid1919894 US20230331675 WANG, Y; ZHANG, N; WU, T; HE, M; WU, X; ZHANG, S 10/19/2023 12/1/2023 Guangzhou Maxinovel Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=627428 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=317&target=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=627428&enzyme=Programmed+cell+death+1+ligand%2Fprotein+1&column=ki&startPg=0&Increment=50&submit=Search 163558000 485655817 2 MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET 7XAE,5IUS,5JDR,3BIS,3BIK,5GRJ,8AOM,6PV9,4Z18,3SBW,5XJ4,3FN3,7TPS,7XYQ,7C88,8P1O,5N2D,5J89,7OUN,5O45,5N2F,5J8O,7UXQ,7UXP,7UXO,7UX5,6VQN,9QSM,9INU,8K5N,8JBA,8ALX,7NLD,7BEA,6YCR,6RPG,6R3K,5NIU,5GGT,7VUN,7DY7,8XR5,7CZD,8OR1,8RPB,5XXY,5JDS,4ZQK,8ZNL,7DCV,6L8R Programmed cell death 1 ligand 1 PD1L1_HUMAN Q9NZQ7 B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLVVGVVGGLLGSLVLLVWVLAVICSRAARGTIGARRTGQPLKEDPSAVPVFSVDYGELDFQWREKTPEPPVPCVPEQTEYATIVFPSGMGTSSPARRGSADGPRSAQPLRPEDGHCSWPL 5WT9,6JBT,6JJP,9Q8L,8AS0,7CGW,6XKR,8U32,8U31,7CU5,7WVM,6J15,7E9B,6J14,5IUS,6UMT Programmed cell death protein 1 PDCD1_HUMAN Q15116 O00517 Q8IX89